European Journal of Cancer
Volume 46, Issue 13 , Pages 2422-2431 , September 2010

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–Results from two randomised studies

  • Thomas Hogberg

      Affiliations

    • Department of Cancer Epidemiology, University of Lund, University Hospital, SE-221 85 Lund, Sweden
    • Corresponding Author InformationCorresponding author: Tel.: +46 46 177550; fax: +46 46 188143.
    • ,
  • Mauro Signorelli

      Affiliations

    • Department of Obstetrics and Gynaecology, A. Manzoni Hospital, Lecco, Italy
    • ,
  • Carlos Freire de Oliveira

      Affiliations

    • Department of Gynaecology, University Hospital, Coimbra, Portugal
    • ,
  • Roldano Fossati

      Affiliations

    • Department of Oncology, Mario Negri Institute, Milan, Italy
    • ,
  • Andrea Alberto Lissoni

      Affiliations

    • Department of Gynaecology and Obstetrics, S. Gerardo Hospital, Monza, Italy
    • ,
  • Bengt Sorbe

      Affiliations

    • Department of Gynaecological Oncology, University Hospital, Örebro, Sweden
    • ,
  • Håkan Andersson

      Affiliations

    • Department of Gynaecological Oncology, University Hospital, Gothenburg, Sweden
    • ,
  • Seija Grenman

      Affiliations

    • Department of Obstetrics and Gynaecology, University Hospital, Turku, Finland
    • ,
  • Caroline Lundgren

      Affiliations

    • Department of Gynaecological Oncology, Radiumhemmet, Karolinska Hospital Solna, Stockholm, Sweden
    • ,
  • Per Rosenberg

      Affiliations

    • Department of Gynaecological Oncology, University Hospital, Linköping, Sweden
    • ,
  • Karin Boman

      Affiliations

    • Department of Gynaecological Oncology, University Hospital, Umeå, Sweden
    • ,
  • Bengt Tholander

      Affiliations

    • Department of Oncology, University Hospital, Uppsala, Sweden
    • ,
  • Giovanni Scambia

      Affiliations

    • Department of Obstetrics and Gynaecology, Gemelli Hospital, Rome, Italy
    • ,
  • Nicholas Reed

      Affiliations

    • Beatson Oncology Centre, Western Infirmary, Glasgow, UK
    • ,
  • Gennaro Cormio

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Bari, Bari, Italy
    • ,
  • Germana Tognon

      Affiliations

    • Department of Obstetrics and Gynaecology, Spedali Civili, Brescia, Italy
    • ,
  • Jackie Clarke

      Affiliations

    • Belfast City Hospital, Belfast, UK
    • ,
  • Tomasz Sawicki

      Affiliations

    • Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
    • ,
  • Paolo Zola

      Affiliations

    • Department of Obstetrics and Gynaecology, Mauriziano Hospital, Turin, Italy
    • ,
  • Gunnar Kristensen

      Affiliations

    • Department of Gynaecological Oncology and Institute of Medical Informatics, The Norwegian Radium Hospital, Oslo, Norway

Received 21 April 2010 ,Revised 26 May 2010 ,Accepted 2 June 2010.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S105–S143
  3. Aalders JG, Abeler VM, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol. 1980;56:419–426
  4. Creutzberg CL, van Putten WLJ, Koper PCM, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet. 2000;355:1404–1411
  5. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–751
  6. Blake P, Swart AM, Orton J, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137–146
  7. Hogberg T, Rosenberg P, Kristensen G, et al. A randomized phase-III study on adjuvant treatment with radiation (RT)±chemotherapy (CT) in early stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol 2007;25(18S) [abstract 5503].
  8. Thigpen T, Blessing J, Homesley H, et al. Phase III trial of doxorubicin±cisplatin in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group (GOG) study. Proc Am Soc Clin Oncol 1993;12 (abstract 830).
  9. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31:103–115
  10. Signorelli M, Lissoni AA, Cormio G, et al. Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study. Ann Surg Oncol. 2009;16:3431–3441
  11. Benedetti PP, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–1716
  12. Cox DR. Regression models and life tables. J Royal Statist Soc. 1972;34:187–220
  13. Barthel FM-S, Royston P. Graphical representation of interactions. Stata J. 2006;6:358–363
  14. Scholten AN, van Putten WL, Beerman H, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys. 2005;63:834–838
  15. Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicine as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;36:166–171
  16. Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2006;24:36–44
  17. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Brit J Cancer. 2006;95:266–271
  18. Susumu N, Sagae S, Udagawa Y, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol. 2008;108:226–233
  19. Greven K, Winter K, Underhill K, et al. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol. 2006;103:155–159

PII: S0959-8049(10)00477-6

doi: 10.1016/j.ejca.2010.06.002

European Journal of Cancer
Volume 46, Issue 13 , Pages 2422-2431 , September 2010

Article Tools

* Image Usage & Resolution